Oura Agrees to Acquire Counsel Health to Connect AI and Physician Care

Oura has agreed to acquire Counsel Health for $625 million in cash, subject to purchase-price adjustments, Counsel Health announced on November 10, 2026. The transaction would pair the smart-ring maker’s continuous biometric data with Counsel’s medical AI and on-demand physicians, extending Oura’s platform into primary care.

The definitive agreement has not yet closed. The companies expect to complete the transaction before the end of 2026, subject to customary closing conditions.

Inside Counsel’s Clinical Workflow

Counsel’s patient experience begins with an AI chat that can use connected medical records, previous interactions, evidence-based clinical guidelines and continuous biometric data to personalize guidance. Its clinical AI harness calls on specialized agents for medical history-taking, guideline retrieval, records review and emergency detection.

Counsel says each agent is evaluated for performance, safety and quality, then improved using feedback from its physicians. Patients can add a Counsel physician during a chat; the physician can provide a diagnosis, prescriptions and referrals when appropriate.

Doctors work through a proprietary Clinician Cockpit, which combines the patient’s medical record with longitudinal health trends to produce context-aware clinical suggestions. Muthu Alagappan, Counsel Health’s founder and chief executive, said Oura’s data gives clinicians “objective context, trended biometrics, and member engagement to deliver more informed care.”

Existing Integration and Expansion Plans

An existing integration lets Oura members move from an Oura health insight into a conversation with Counsel’s medical AI. If human care is needed, a board-certified Counsel physician can join within minutes, with the interaction remaining inside the Oura App.

The companies reported that more than 90% of surveyed Oura members using Counsel said their Oura data helped them obtain better care. Members who saw a Counsel physician rated the care experience 4.6 out of 5.

The companies plan to extend their collaboration across preventive, acute, specialty and chronic care. Continuous monitoring would support earlier recognition of possible health changes, while the acute-care service would address episodic concerns with guidance, support or prescriptions. Ongoing support would include reproductive health, aging and cardiometabolic health.

Under the post-acquisition plan, Counsel will continue serving existing and new enterprise partners, including health plans, health systems, consumer health organizations and employers. Oura executive chairman David Shuman said those relationships could extend the combined company’s reach to millions of people beyond Oura’s current members and expand its addressable market.

Oura’s Financial Context

Alongside the agreement, Oura reported preliminary, unaudited revenue of $533 million for the quarter ended September 30, 2026, a 153% year-over-year increase. Fiscal 2026 revenue was approximately $1.75 billion, up 92%, and the company has more than six million members. The financial results may change as Oura completes its year-end close and audit.

The purchase would add a clinical workforce and enterprise care distribution to Oura’s biometric platform, while connecting Counsel more closely to a continuous source of patient health data. The practical test is whether Oura can turn biometric insights into timely, physician-supervised care across both its app and Counsel’s enterprise channels while preserving a clear handoff between AI guidance and clinical decisions.